HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 295/6/R1782    most recent 90635.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cummings, B. P. Articles by Havel, P. J. Search for Related Content PubMed PubMed Citation Articles by Cummings, B. P. Articles by Havel, P. J.

ENDOCRINE PHYSIOLOGY AND METABOLISM

Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat

¹Department of Molecular Biosciences, School of Veterinary Medicine; ²Department of Nutrition, University of California, Davis, California; ³Research and Development Service, Department of Veterans Affairs Puget Sound Health Care System and Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition; ⁴Department of Medicine, University of Washington, Seattle, Washington; and ⁵Department of Internal Medicine, University of California, Davis, Sacramento, California

Submitted 27 July 2008 ; accepted in final form 26 September 2008

The prevalence of type 2 diabetes (T2DM) is increasing, creating a need for T2DM animal models for the study of disease pathogenesis, prevention, and treatment. The purpose of this project was to develop a rat model of T2DM that more closely models the pathophysiology of T2DM in humans. The model was created by crossing obese Sprague-Dawley rats with insulin resistance resulting from polygenic adult-onset obesity with Zucker diabetic fatty-lean rats that have a defect in pancreatic β-cell function but normal leptin signaling. We have characterized the model with respect to diabetes incidence; age of onset; longitudinal measurements of glucose, insulin, and lipids; and glucose tolerance. Longitudinal fasting glucose and insulin data demonstrated progressive hyperglycemia (with fasting and fed glucose concentrations >250 and >450 mg/dl, respectively) after onset along with hyperinsulinemia resulting from insulin resistance at onset followed by a progressive decline in circulating insulin concentrations, indicative of β-cell decompensation. The incidence of diabetes in male and female rats was 92 and 43%, respectively, with an average age of onset of 6 mo in males and 9.5 mo in females. Results from intravenous glucose tolerance tests, pancreas immunohistochemistry, and islet insulin content further support a role for β-cell dysfunction in the pathophysiology of T2DM in this model. Diabetic animals also exhibit glycosuria, polyuria, and hyperphagia. Thus diabetes in the UC Davis-T2DM rat is more similar to clinical T2DM in humans than in other existing rat models and provides a useful model for future studies of the pathophysiology, treatment, and prevention of T2DM.

diabetic rodent model; hyperglycemia; insulin; β-cell

This article has been cited by other articles:

				S. Reinwald, R. G. Peterson, M. R. Allen, and D. B. Burr Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent models Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E765 - E774. [Abstract] [Full Text] [PDF]